Singapore Markets closed
Straits Times Index
3,426.47 -3.98 (-0.12%) Nikkei
37,667.41 -202.10 (-0.53%) Hang Seng
17,021.31 +16.34 (+0.10%) FTSE 100
8,285.71 +99.36 (+1.21%) BTC-USD
67,879.34 +2,201.39 (+3.35%) CMC Crypto 200
1,376.39 +45.78 (+3.44%)
Incyte Corporation (INCY)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 68.57 |
| Open | 68.57 |
| Bid | 68.58 x 400 |
| Ask | 68.67 x 600 |
| Day's range | 68.24 - 69.85 |
| 52-week range | 50.27 - 70.36 |
| Volume | |
| Avg. volume | 3,650,052 |
| Market cap | 13.517B |
| Beta (5Y monthly) | 0.74 |
| PE ratio (TTM) | 20.79 |
| EPS (TTM) | 3.30 |
| Earnings date | 30 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 71.98 |
ZacksIs a Beat in the Cards for Incyte (INCY) in Q2 Earnings?
On Incyte's (INCY) second-quarter 2024 earnings call, investors' focus is likely to be on the sales performance of its lead drug, Jakafi, which has been facing stiff competition.
ZacksQiagen (QGEN) Expected to Beat Earnings Estimates: Should You Buy?
Qiagen (QGEN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksIncyte (INCY) Reports Next Week: Wall Street Expects Earnings Growth
Incyte (INCY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2024 Yahoo. All rights reserved.